{"id":345,"date":"2023-04-25T14:40:54","date_gmt":"2023-04-25T14:40:54","guid":{"rendered":"https:\/\/eastmedia.lt\/picnichealth-roche-partneris-siekiantis-paspartinti-neurologiniu-ligu-tyrimus\/"},"modified":"2023-04-25T14:40:54","modified_gmt":"2023-04-25T14:40:54","slug":"picnichealth-roche-partneris-siekiantis-paspartinti-neurologiniu-ligu-tyrimus","status":"publish","type":"post","link":"https:\/\/easa.lt\/index.php\/2023\/04\/25\/picnichealth-roche-partneris-siekiantis-paspartinti-neurologiniu-ligu-tyrimus\/","title":{"rendered":"\u201ePicnicHealth\u201c, \u201eRoche\u201c partneris, siekiantis paspartinti neurologini\u0173 lig\u0173 tyrimus"},"content":{"rendered":"

<\/p>\n

\n

Sveikatos technologij\u0173 \u012fmon\u0117 <\/span>\u201ePicnicHealth\u201c, farmacijos mil\u017ein\u0117 \u201eRoche\u201c ir jos dukterin\u0117 \u012fmon\u0117 \u201eGenentech\u201c ple\u010dia savo partneryst\u0119 visame pasaulyje, kad paspartint\u0173 neurologini\u0173 lig\u0173 tyrimus investuodami \u012f realaus pasaulio duomenis.<\/p>\n

\u201ePicnicHealth\u201c leid\u017eia pacientams matyti savo sveikatos istorij\u0105 ir \u012ftraukti savo medicininius duomenis, kuri\u0173 tapatyb\u0117 nebuvo nustatyta, atliekant klinikinius tyrimus. <\/span><\/p>\n

\u201eRoche\u201c naudos naujausius \u201ePicnicHealth\u201c realaus pasaulio duomen\u0173 rinkinius <\/span>Alzheimerio liga, su Alzheimerio liga susijusi demencija ir myasthenia gravis \u2013 l\u0117tinis autoimuninis sutrikimas, d\u0117l kurio susilpn\u0117ja griau\u010di\u0173 raumenys.<\/p>\n

Duomen\u0173 rinkiniai bus naudojami Roche bendrame neuromoksliniame pacient\u0173 tyrime, teikiant informacij\u0105 apie nepatenkintus poreikius ir i\u0161\u0161\u016bkius, su kuriais susiduria pacientai, sergantys neurologin\u0117mis ligomis. <\/span><\/p>\n

\u201eD\u017eiaugiam\u0117s gal\u0117dami t\u0119sti ilgalaik\u0119 partneryst\u0119 su Roche ir Genentech, nes pasitelkiame savo patirt\u012f dirbdami su pacientais, kad gautume duomenis, o mokslininkai gal\u0117t\u0173 geriau suprasti ligos progresavim\u0105 ir stadij\u0105 bei holistin\u012f neurologin\u0117s ligos poveik\u012f pacientui ir jos prie\u017ei\u016bros komandos\u201c, \u2013 prane\u0161ime teig\u0117 \u201ePicnicHealth\u201c vyriausiasis medicinos pareig\u016bnas daktaras Danas Drozdas. <\/span><\/p>\n

DIDESN\u0116 TENDENCIJA<\/span> <\/strong><\/p>\n

Pra\u0117jusiais metais \u201ePicnicHealth\u201c i\u0161k\u0117l\u0117 <\/span>60 milijon\u0173 JAV doleri\u0173 C serijos finansavimui, pra\u0117jus dvejiems metams po to, kai ji u\u017edirbo 35 milijonus doleri\u0173 akcinio kapitalo.<\/p>\n

Pra\u0117jusiais metais duomen\u0173 bendrov\u0117 <\/span>paskelb\u0117 apie partneryst\u0119 su pasauline biofarmacijos \u012fmone Bristol Myers Squibb, siekdama sujungti duomen\u0173 rinkinius, kad geriau suprast\u0173 pacientus, sergan\u010dius obstrukcine hipertrofine kardiomiopatija. <\/p>\n

Anks\u010diau \u0161\u012f m\u0117nes\u012f \u201ePicnicHealth\u201c. <\/span>paskelb\u0117, kad bendradarbiaus su CureDuchenne, pasauline ne pelno organizacija, kurios tikslas \u2013 rasti vaist\u0173 nuo Diu\u0161eno raumen\u0173 distrofijos, kad sustiprint\u0173 bendrov\u0117s realaus pasaulio \u012frodym\u0173 generavim\u0105 savo platformai CureDuchenne Link. <\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Sveikatos technologij\u0173 \u012fmon\u0117 \u201ePicnicHealth\u201c, farmacijos mil\u017ein\u0117 \u201eRoche\u201c ir jos dukterin\u0117 \u012fmon\u0117 \u201eGenentech\u201c ple\u010dia savo partneryst\u0119 visame pasaulyje, kad paspartint\u0173 neurologini\u0173 lig\u0173 tyrimus investuodami \u012f realaus pasaulio duomenis. \u201ePicnicHealth\u201c leid\u017eia pacientams matyti savo sveikatos istorij\u0105 ir \u012ftraukti savo medicininius duomenis, kuri\u0173 tapatyb\u0117 nebuvo nustatyta, atliekant klinikinius tyrimus. \u201eRoche\u201c naudos naujausius \u201ePicnicHealth\u201c realaus pasaulio duomen\u0173 rinkinius Alzheimerio […]<\/p>\n","protected":false},"author":2,"featured_media":346,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-345","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bendri"],"_links":{"self":[{"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/posts\/345","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/comments?post=345"}],"version-history":[{"count":0,"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/posts\/345\/revisions"}],"wp:attachment":[{"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/media?parent=345"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/categories?post=345"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/tags?post=345"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}